bioAffinity Technologies (BIAF) Cash from Investing Activities Growth (1y) (2024 - 2026)
bioAffinity Technologies (BIAF) Cash from Investing Activities Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -3,832.95% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 24.18% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -10.12% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -91.12% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 95.92% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -8.06% |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | 88.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.85% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 138.75% |
| Jun 30, 2025 | 52.53% |
| Mar 31, 2025 | -22.71% |
| Dec 31, 2024 | -100.01% |
| Sep 30, 2024 | 99.57% |
| Jun 30, 2024 | -632.58% |
| Mar 31, 2024 | -28.08% |